ArticleEBioMedicine2026
P2Y12-P-selectin-mediated platelet activation in a murine model of dengue-associated thrombocytopenia.
Article in EBioMedicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- P-Selectin and Platelet-Monocyte Interaction in Inflammation: Mechanisms, Hypothesis, and Open Questions.Journal of inflammation research · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
20 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundDengue virus (DENV) infection frequently leads to thrombocytopenia, a hallmark of severe disease. However, the underlying mechanisms remain incompletely defined. Therefore, this study aimed to investigate the mechanisms underlying dengue-associated thrombocytopenia in a murine model, with a focus on defective thrombopoiesis and platelet activation.
methodsUsing a murine model that recapitulates key haematological and inflammatory features of human dengue, we investigated the impact of DENV infection on megakaryopoiesis, platelet activation, and thromboinflammatory responses. Bone marrow cellularity, megakaryocyte integrity, circulating cytokines and chemokines, platelet activation markers, and vascular injury were assessed. Pharmacological inhibition of P-selectin and blockade of the P2Y12 receptor with clopidogrel were used to evaluate the contribution of platelet activation pathways.
findingsDENV infection impaired megakaryopoiesis, inducing necrotic loss of bone marrow megakaryocytes and leukocytes as early as day 3 post-infection, accompanied by bone marrow aplasia and a compensatory increase in thrombopoietin levels. Systemically, infection triggered P-selectin-dependent platelet activation and platelet-leucocyte aggregate formation, alongside elevated circulating chemokines (CXCL4, CCL5, and CXCL1), vascular leakage in the liver and lungs, and fibrin deposition in pulmonary tissue, consistent with enhanced thromboinflammation. Pharmacological blockade of P-selectin or inhibition of P2Y12 signalling restored platelet counts, preserved megakaryocyte numbers, and attenuated systemic inflammatory responses.
interpretationThese findings indicate that DENV-induced thrombocytopenia arises from the combined effects of impaired megakaryopoiesis and platelet hyperactivation, highlighting platelet activation pathways as potential therapeutic targets for dengue-associated thromboinflammatory complications.
fundingThis work was supported by CNPq, FAPEMIG, Instituto Serrapilheira, and the ASH Global Research Award (465425/2014-3; 408527/2024-2; 163937/2022-2; 25036/2014-3; RED-00202-22 29568-1; APQ-04650-23 and APQ-02618 23).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.